scholarly journals Prevalence Rate of Congenital Fetal Malformations in Second Trimester by Ultrasound Scanning in Zagazig University Outpatient Clinic

2021 ◽  
Vol 85 (2) ◽  
pp. 3889-3992
Author(s):  
Ali El-Shabrawy Ali ◽  
Gamal Abbas El-Sayed ◽  
Basem Mohamed Hamed ◽  
Mabruka Ali Omran Tumi
Keyword(s):  
Outpatient Clinic ◽  
Prevalence Rate ◽  
Second Trimester ◽  
Ultrasound Scanning ◽  
Fetal Malformations

scholarly journals The value of routine mid-trimester ultrasound in low-risk pregnancies at primary care level

2008 ◽  
Vol 13 (4) ◽  
pp. 41-49 ◽  
Author(s):  
B Van Dyk ◽  
JA Motto ◽  
EJ Buchmann
Keyword(s):  
Antenatal Care ◽  
Low Birthweight ◽  
Controlled Trial ◽  
Open Cluster ◽  
Mode Of Delivery ◽  
Low Risk ◽  
Control Group ◽  
Ultrasound Scan ◽  
Second Trimester ◽  
Ultrasound Scanning

This study investigated the effect of routine second-trimester ultrasound scanning on obstetric management and pregnancy outcomes. This was an open cluster, randomised, controlled trial. Clusters of women with low-risk pregnancies presenting in the second trimester were randomised to receive an ultrasound scan followed by usual antenatal care, or to an unscanned control group undergoing conventional antenatal care only. Out of the 962 women randomised, follow-up was successful for 804 (83.6%), with 416 allocated to the ultrasound scan group and 388 controls. There were no significant differences between the ultrasound scan group and the control group in terms of prenatal hospitalisation, mode of delivery, miscarriage, perinatal mortality rate and low birthweight rate. Ultrasound dating was associated with a lower rate of induction of labour for post-term pregnancy (1.4% vs. 3.6%; P=0.049). However, ultrasound scanning in low-risk pregnancies was not associated with improvements in pregnancy outcome. Opsomming Hierdie studie het die effek van roetine mid-trimester ultraklankskandering op swangerskapsorg en –uitkomste ondersoek. Dit was ’n oop tros, lukrake, beheerde proef. Groepe vroue met laerisikoswanger- skap in die midtrimester is lukraak toegewys vir ’n ultraklank-skandering, gevolg deur voorgeskrewe voorgeboor-tesorg, of vir ’n kontrolegroep wat voorgeboortesorg volgens nasionaal voorgeskrewe protokol sonder skandering ontvang het. Van die 962 vroue wat aan die steekproef deelgeneem het kon data vir 804 (83.6%) suksesvol opgevolg word, met 416 in die ultraklankgroep en 388 in die kontrolegroep. Geen beduidende verskille is tussen die twee groepe gevind ten opsigte van voorgeboorte-hospitalisasie, geboortemetode, miskraamstatistiek, perinatale komplikasies of laegeboortegewig nie. Ultraklankdatering van swangerskappe is met minder kraaminduksie (1.4% teen 3.6%; P=0.049) vir natrimesterswangerskap geassosieer. Roetine ultraklankskandering in laerisikoswangerskap het egter geen verbetering in swangerskapsuitkomste te weeg gebring nie.

scholarly journals P28.14: Correlation between ultrasound diagnosis and autopsy findings of fetal malformations in second trimester terminations of pregnancy

2010 ◽  
Vol 36 (S1) ◽  
pp. 281-281
Author(s):  
A. Vimercati ◽  
S. Grasso ◽  
A. de Gennaro ◽  
E. Bassi ◽  
I. Cobuzzi ◽  
...  
Keyword(s):  
Ultrasound Diagnosis ◽  
Second Trimester ◽  
Autopsy Findings ◽  
Fetal Malformations

3D / 4D US in Fetal Malformations [Part 2. Second Trimester: Cephalic Pole Malformations]

2008 ◽  
pp. 56-86
Author(s):  
Fernando Bonilla-Musoles ◽  
Luiz Eduardo Machado ◽  
Franciso Raga ◽  
Juan Carlos Castillo ◽  
Newton Osborne ◽  
...  
Keyword(s):  
Second Trimester ◽  
Fetal Malformations

scholarly journals Fetal Anatomical Survey during Second Trimester Screening Examination

2012 ◽  
Vol 6 (1) ◽  
pp. 43-54
Author(s):  
Armando Pintucci ◽  
Vincenzo Pinto ◽  
Luca Di Cagno ◽  
Angela Cristina Rossi ◽  
Vincenzo D'Addario
Keyword(s):  
Gestational Age ◽  
Congenital Malformations ◽  
Pregnant Patient ◽  
Systematic Evaluation ◽  
Second Trimester ◽  
Fetal Anomalies ◽  
Screening Examination ◽  
Second Trimester Screening ◽  
Trimester Screening ◽  
Fetal Malformations

ABSTRACT Screening for fetal malformations is one of the main aims of ultrasonography during pregnancy. In most cases fetal anomalies occur as an unexpected event in not at risk patients: For this reason the only way to rule out congenital malformations is to screen every pregnant patient with a systematic evaluation of the fetal anatomy. The ultrasonic screening of fetal malformations has to be based on a single examination that has to be planned at a gestational age which is advanced enough to visualize most fetal anomalies and early enough to plan further diagnostic tests and allow the termination of pregnancy in the case of severe malformation. The gestational age that constitutes the best compromise between the need of an early diagnosis and the natural history of most congenital malformations is the period ranging from 19 to 21 weeks of gestation. This ultrasonic examination is known as ‘fetal anomaly scan’ or ‘fetal morphology scan’. Some scientific societies suggest guidelines for the optimal performance of such examination. In this paper the minimal standards for an accurate ‘fetal morphology scan’ will be described. How to cite this article D'Addario V, Pinto V, Di Cagno L, Pintucci A, Rossi AC. Fetal Anatomical Survey during Second Trimester Screening Examination. Donald School J Ultrasound Obstet Gynecol 2012;6(1):43-54.

scholarly journals Pregnancy outcomes regarding maternal serum AFP value in second trimester screening

2017 ◽  
Vol 45 (7) ◽  
Author(s):  
Karolina Bartkute ◽  
Dalia Balsyte ◽  
Josef Wisser ◽  
Juozas Kurmanavicius
Keyword(s):  
Gestational Age ◽  
Pregnancy Outcomes ◽  
Maternal Serum ◽  
Adverse Pregnancy Outcomes ◽  
Fetal Malformation ◽  
Second Trimester ◽  
Second Trimester Screening ◽  
Newborn Weight ◽  
Fetal Malformations ◽  
Adverse Pregnancy

AbstractAim:The aim of this study was to evaluate the predictive value of α-fetoprotein in maternal serum (MS-AFP) as a marker for diverse pregnancy outcomes.Methods:The study was based on pregnancy and delivery data from 5520 women between 1999 and 2014 at University Hospital of Zurich (UHZ). Inclusion criteria: both MS-AFP and pregnancy outcome were known for the same pregnancy. Pregnancy outcomes and characteristics such as fetal malformation, intrauterine fetal death (IUFD) and intrauterine growth retardation as well as maternal age, weight before pregnancy, gestational age (GA) at delivery, newborn weight, length and head circumference were analyzed with respect to the MS-AFP value. MS-AFP value was categorized into three groups: elevated MS-AFP>2.5 multiples of the median (MoM), normal 0.5–2.49 MoM and decreased <0.5 MoM.Results:Newborn weight (g) and length (cm) were significantly lower in the elevated MS-AFP (P<0.001) group, and infants had 1 week lower GA at delivery (P<0.05). In the group of elevated MS-AFP (n=46), 26.1% of pregnancies were significantly related to adverse pregnancy outcomes, such as fetal malformations, fetuses small for gestational age (SGA) and IUFD. Adverse pregnancy outcomes of 5.6% were registered in the group of normal MS-AFP and 7.3% in the group of low MS-AFP (P<0.05).Conclusion:MS-AFP level in the second trimester is still an important indicator of fetal surface malformations; however, ultrasound still outweighs as a screening method. Nevertheless, pregnant women with elevated MS-AFP values and with no sonographically detected fetal malformations should additionally receive the third trimester ultrasound examination to exclude other possible complications of pregnancy.

Sign in / Sign up

Export Citation Format

Share Document